Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-16

Clinical Trial Update: Use of Insulin Glargine to Treat Diabetic Ketoacidosis [NA]

View source ↗

Summary

The clinical trial evaluating insulin glargine as a treatment for diabetic ketoacidosis has completed. Results were posted on 2018-07-16.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lantus (insulin glargine)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Diabetic Ketoacidosis | NA | Status: COMPLETED | Results posted: 2018-07-16